HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Weighs In On Federal Microbead Bill At Committee Hearing

This article was originally published in The Rose Sheet

Executive Summary

At a May 1 House Energy and Commerce Committee hearing, legislators probed stakeholders for their views on the Microbead-Free Waters Act of 2015, introduced in March. The bill calls for the ban of synthetic plastic microbeads in personal-care products starting Jan. 1, 2018, and industry supports the inclusion of OTC drugs as well, while stressing that industry needs a clear microbead definition and time to adapt.

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts